The Latest Cardiac and Vascular News
SEATTLE–(BUSINESS WIRE)–Kestra Medical Technologies is launching the ASSURE Clinician Experience (ACE), a program that lets electrophysiology and cardiology professionals wear and simulate use of the ASSURE® Wearable Cardioverter Defibrillator (WCD) system at The Heart Rhythm Society #HRX2023 global health and technology conference, September 21-23, 2023 in Seattle, WA. Clinicians that participate will be […]
ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access. The unique […]
BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today the opening of its new global headquarters at 451 D Street in Boston, Mass. The new 9,365-square-foot space in the Seaport District will […]
REHOVOT, Israel–(BUSINESS WIRE)–Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based, leaflet modification solutions for treating heart valves, announced today the successful completion of its ShortCut™ Pivotal Study enrollment. ShortCut™ is the world’s first dedicated device designed to split the leaflets of pre-existing valves to enable safe Transcatheter […]
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce that it has been honored with the Editor’s Choice designation as the Top MedTech Startup for 2023 by MedTech Outlook. “We are glad to feature CorVista Health as the Editor’s Choice […]
SUNNYVALE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors. Proceeds from the financing will support the clinical advancement of Corsair’s lead product candidate, […]
Southlake, TX, Sept. 21, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced it has executed definitive agreements with the Icahn School of Medicine […]
MILAN, Sept. 21, 2023 /PRNewswire/ — Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI)-powered image acquisition, have entered into a global agreement in the field of magnetic resonance imaging (MRI). This global agreement will begin primarily in the United States, where Bracco […]
SARASOTA, Fla., Sept. 20, 2023 /PRNewswire/ — PaceMate®, a market leading cardiac data management platform, announced today industry partnership with MedAxiom, the cardiovascular community’s premier source for organizational performance solutions. PaceMate offers comprehensive and flexible cardiac data management software and 24.7.365 clinical service and communications solutions. PaceMate is the market leader in electronic health […]
TORONTO, CA, September 18, 2023 – Conavi Medical, Inc. (www.conavi.com), a leader in hybrid intravascular imaging, is pleased to announce the close of $12.5 mil USD of funding, including participation from existing investors. The round was led by CPOINT Capital, which is a professional life science investment firm with an […]
